<DOC>
	<DOCNO>NCT02677610</DOCNO>
	<brief_summary>This double-blind , randomize , vehicle-controlled , multi-center , parallel group Phase 3 study MSRD-100 treatment atopic dermatitis subject age 3 month .</brief_summary>
	<brief_title>Efficacy Safety Study MSRD-100 Subjects With Atopic Dermatitis &gt; =3 Months Age Older</brief_title>
	<detailed_description>This 4-week efficacy , safety tolerability study MSRD-100 applied twice daily 4 week compare vehicle among subject ≥3 month age treatment atopic dermatitis cover ≥5 % body surface area . The study consist 4 visit include Screening - Visit 1 ( Screening ) , Baseline - Visit 2 , Visit 3 ( Day 14 ) , End Treatment/Final Study Visit - Visit 4 ( Day 28 ) . Study IDs M169981001 M169981002 two identical study run parallel different study site .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Key 1 . Subjects male female , ≥3 month age date Baseline Visit . 2 . Subjects diagnosis atopic dermatitis , active inflammation meeting Hanifin Rajka Diagnosis Criteria Atopic Dermatitis . 3 . Subjects must Investigator Global Assessment ( IGA ) score ≥2 baseline . 4 . Subjects atopic dermatitis cover ≥5 % Body Surface Area ( BSA ) exclude eyelid , perioral area , around nostril , diaper area ( subject wear diaper plastic pant ) . 5 . Subjects atopic dermatitis sign symptom score ≥ 2 follow three sign symptom : erythema , infiltration/papulation , erosion/oozing/crusting present least one body surface area affect . Key 1 . Unstable course Atopic Dermatitis ( spontaneously improve rapidly deteriorate ) determine investigator previous 4 week prior baseline . 2 . Concurrent condition history disease . 3 . Used follow treatment within indicate washout period baseline visit would require follow study . 4 . Subjects require treatment topical systemic therapy study disease bland emollient untreated area disease .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dermatitis , Atopic</keyword>
	<keyword>Eczema</keyword>
	<keyword>Dermatitis</keyword>
	<keyword>Pruritus</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
	<keyword>Hypersensitivity</keyword>
	<keyword>Hypersensitivity , Immediate</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Skin Diseases , Eczematous</keyword>
	<keyword>Skin Diseases , Genetic</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>Itching</keyword>
	<keyword>Rash</keyword>
	<keyword>Steroid</keyword>
</DOC>